SciTransfer
EUREMAP · Project

European Integrated Service Platform for Discovering New Marine-Based Drugs and Bio-Products

healthTestedTRL 5

Imagine the ocean as a giant, untapped pharmacy where most of the medicines are hidden in strange sea creatures. Instead of every lab trying to find these alone, this project builds a shared 'super-highway' that connects experts in genetics, chemistry, and data. It makes it much faster and cheaper for companies to find and test these natural ingredients for new products.

By the numbers
13
partners
8
countries
3
integrated Research Infrastructures (EU-OS, EMBRC, ELIXIR)
The business problem

What needed solving

Finding new bioactive compounds in the ocean is slow, fragmented, and expensive because the necessary tools for genomics, chemistry, and data are scattered across different institutions.

The solution

What was built

A trans-RI integrated service platform that links genomics, culturomics, green chemistry, and data management into a single technical pipeline.

Audience

Who needs this

Pharmaceutical R&D departmentsMarine biotechnology companiesSpecialty chemical manufacturersCosmetic ingredient developers
Business applications

Who can put this to work

Pharmaceuticals
enterprise
Target: Drug discovery firm

If you are a drug discovery firm dealing with the high cost of finding new bioactive leads — this project developed a trans-RI integrated service that links genomics and chemistry to accelerate the discovery of novel natural products.

Biotechnology
SME
Target: Marine biotech startup

If you are a marine biotech startup dealing with a lack of specialized screening equipment — this project developed a service portfolio integrating EU-OPENSCREEN, EMBRC, and ELIXIR to provide bioactivity screening and data management.

Cosmeceuticals
mid-size
Target: High-end skincare manufacturer

If you are a skincare manufacturer dealing with the difficulty of sourcing sustainable marine ingredients — this project developed a pipeline for BGC discovery and natural product chemistry to identify sustainable bioactive compounds.

Frequently asked

Quick answers

What is the cost or pricing for using these services?

Based on available project data, specific pricing is not listed, but the project has established procedures for industry collaboration via WP13.

Can these discovery processes be scaled to an industrial level?

The project focuses on optimizing the bioprospecting pipeline to increase the competitiveness of marine natural products, though specific industrial scale-up metrics are not provided.

How is IP and licensing handled for discovered compounds?

Based on available project data, the project has established governance structures and procedures for industry engagement in WP13 to manage these collaborations.

How does this integrate with existing company data?

The project implemented a Data Interoperability Roadmap and tools like OpenAIRE Argos and Zenodo to ensure open data sharing and integration.

What is the timeline for accessing these services?

The project runs from 2024-01-01 to 2026-12-31, with service portfolios and industry engagement procedures already being developed.

Consortium

Who built it

The consortium is heavily weighted toward research and academia, consisting of 9 research organizations and 4 universities across 8 countries. Notably, there are 0 industry partners and 0 SMEs involved in the core consortium, meaning the current output is primarily academic-driven, though WP13 is specifically dedicated to creating the bridge for industry engagement.

How to reach the team

Contact Universitetet i Tromsø - Norges Arktiske Universitet

Next steps

Talk to the team behind this work.

Contact us to connect with the EUREMAP service platform for marine bioprospecting.

More in Health & Biomedical
See all Health & Biomedical projects